Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32,967Revenue (TTM) $M20,292Net Margin (%)8.9Altman Z-Score0.8
Enterprise Value $M73,784EPS (TTM) $1.7Operating Margin %15.9Piotroski F-Score3
P/E(ttm)18.8Beneish M-Score-2.0Pre-tax Margin (%)12.8Higher ROA y-yN
Price/Book1.110-y EBITDA Growth Rate %11.2Quick Ratio0.6Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %2.5Current Ratio0.9Lower Leverage y-yN
Price/Free Cash Flow6.5y-y EBITDA Growth Rate %162ROA % (ttm)2.9Higher Current Ratio y-yN
Dividend Yield %4.2PEG7.7ROE % (ttm)5.4Less Shares Outstanding y-yN
Payout Ratio %79.0Shares Outstanding M1,015ROIC % (ttm)5.6Gross Margin Increase y-yN

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVANWQ Managers 2016-09-30 Add0.66%$46.01 - $55.45
($52.17)
$ 32.71-37%Add 58.75%2,663,631
TEVAJohn Paulson 2016-09-30 Reduce-0.36%$46.01 - $55.45
($52.17)
$ 32.71-37%Reduce -4.15%16,076,900
TEVABarrow, Hanley, Mewhinney & Strauss 2016-09-30 Add0.27%$46.01 - $55.45
($52.17)
$ 32.71-37%Add 17.05%26,570,988
TEVAMichael Price 2016-09-30 Add0.18%$46.01 - $55.45
($52.17)
$ 32.71-37%Add 6.59%469,300
TEVAVanguard Health Care Fund 2016-09-30 Add0.04%$46.01 - $55.45
($52.17)
$ 32.71-37%Add 6.13%6,746,400
TEVADavid Dreman 2016-09-30 Reduce-0.04%$46.01 - $55.45
($52.17)
$ 32.71-37%Reduce -3.92%31,969
TEVARonald Muhlenkamp 2016-09-30 Reduce-0.02%$46.01 - $55.45
($52.17)
$ 32.71-37%Reduce -0.50%175,770
TEVAKeeley Asset Management Corp 2016-09-30 Reduce$46.01 - $55.45
($52.17)
$ 32.71-37%Reduce -2.23%56,869
TEVAJulian Robertson 2016-06-30 Sold Out -4.78%$48.53 - $57.25
($53.24)
$ 32.71-39%Sold Out0
TEVAJohn Paulson 2016-06-30 Reduce-1.55%$48.53 - $57.25
($53.24)
$ 32.71-39%Reduce -18.58%16,773,800
TEVABarrow, Hanley, Mewhinney & Strauss 2016-06-30 Add1.03%$48.53 - $57.25
($53.24)
$ 32.71-39%Add 143.69%22,700,812
TEVAFirst Eagle Investment 2016-06-30 Reduce-0.26%$48.53 - $57.25
($53.24)
$ 32.71-39%Reduce -99.99%200
TEVANWQ Managers 2016-06-30 Reduce-0.24%$48.53 - $57.25
($53.24)
$ 32.71-39%Reduce -14.45%1,677,841
TEVAKeeley Asset Management Corp 2016-06-30 Add0.03%$48.53 - $57.25
($53.24)
$ 32.71-39%Add 32.85%58,169
TEVARonald Muhlenkamp 2016-06-30 Reduce-0.01%$48.53 - $57.25
($53.24)
$ 32.71-39%Reduce -0.29%176,655
TEVADavid Dreman 2016-06-30 Reduce$48.53 - $57.25
($53.24)
$ 32.71-39%Reduce -2.09%33,274
TEVAJulian Robertson 2016-03-31 Reduce-2.02%$53.5 - $65.86
($58.8)
$ 32.71-44%Reduce -40.16%356,200
TEVANWQ Managers 2016-03-31 Add0.49%$53.5 - $65.86
($58.8)
$ 32.71-44%Add 42.10%1,961,208
TEVAFirst Eagle Investment 2016-03-31 Reduce-0.4%$53.5 - $65.86
($58.8)
$ 32.71-44%Reduce -56.18%1,915,660
TEVADavid Dreman 2016-03-31 Buy 0.21%$53.5 - $65.86
($58.8)
$ 32.71-44%New holding33,983
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    Teva: Good Value, Questionable Management? Jan 02 2017 
    Integer Investments: Akorn Has 100% Upside Potential Jan 01 2017 
    4 Stocks Reach Their 3-Year Low Prices Dec 31 2016 
    10 for 2017! Investment Picks for the New Year Dec 23 2016 
    Teva Is a Hold Nov 30 2016 
    Buy Health Care Now? It All Depends on the Election Nov 07 2016 
    John Paulson’s Health Care Picks Plunge in Flat Year for Sector Oct 06 2016 
    Allergan: An Undervalued Powerhouse Aug 28 2016 
    A Comprehensive Look at Dividend Growth Stock Valuations Sector by Sector: Part 2 Aug 26 2016 
    Swiss Generics Manufacturer Has Strong 1st Half of Year Aug 22 2016 

    More From Other Websites
    Canada Wants Painkiller Warnings as Deaths Soar Jan 23 2017
    JP Morgan Downgrades Teva Jan 20 2017
    Teva Pharma downgraded by JP Morgan Jan 20 2017
    Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER Jan 19 2017
    Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval Jan 19 2017
    Teva's Pain Drug Gets Approved By The FDA Jan 18 2017
    FDA approves Teva's abuse-deterrent painkiller Jan 18 2017
    Teva Receives FDA Approval for VANTRELATM ER (Hydrocodone Bitartrate) Extended-Release Tablets... Jan 18 2017
    10 Dividend Growth Stocks That Simply Print Money Jan 17 2017
    5 Trump-Proof Pharma Dividends Up To 5.3% Jan 16 2017
    Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended Jan 16 2017
    Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit Jan 13 2017
    Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva Jan 12 2017
    Patent Victory Secures Lilly Hold on Cancer Drug Until 2022 Jan 12 2017
    Eli Lilly's stock rallies after appeals court upholds favorable patent ruling Jan 12 2017
    Lilly Jumps After Lung Cancer Drug Patent Upheld Jan 12 2017
    These 3 stocks may be the only true value plays left Jan 12 2017
    Drug Stocks Tank As Trump Vows To Attack High Drug Prices Jan 11 2017
    Macy’s, Teva Join Wednesday’s 52-Week Low Club Jan 11 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)